---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-032162"
form_type: "8-K"
ticker: "ASMB"
cik: "0001426800"
company_name: "ASSEMBLY BIOSCIENCES, INC."
filed_at: "2024-03-15T23:59:59+00:00"
generated_at: "2026-06-04T16:59:31.160906+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Assembly Biosciences appoints Gilead designee to board, adopts 2024 bonus plan

## Summary
- Robert D. Cook II, Gilead's VP of Risk Governance and Audit, appointed to Board as Gilead designee per Oct 15, 2023 Investor Rights Agreement; no compensation.
- Compensation Committee approved 2024 Corporate Bonus Plan effective Jan 1 2024 with cash bonuses tied to corporate and individual objectives.
- CEO bonus target up to 75% of base salary; other executive participants 30-55%; non-executive participants up to 28%.
- Cash bonuses range from 0 to 1.5x target; paid by March 15 following performance year; employment through payment date required.
- Weighting: CEO 100% corporate; C-Level/SVP 75/25; VP/Exec Dir/Sr Dir 50/50; below Sr Dir 25/75.

## SEC filing metadata
- accession: 0000950170-24-032162
- form_type: 8-K
- ticker: ASMB
- cik: 0001426800
- company_name: ASSEMBLY BIOSCIENCES, INC.
- filed_at: 2024-03-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1426800/000095017024032162/0000950170-24-032162-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1426800/000095017024032162/asmb-20240312.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-032162
- JSON: https://secwatch.observer/filing/0000950170-24-032162.json
- Plain text: https://secwatch.observer/filing/0000950170-24-032162.txt

## Key facts
- Executive change
  Robert D. Cook II was appointed as Director at ASSEMBLY BIOSCIENCES, INC..
  - Action: appointed
  - Role: Director
  source text: On March 13, 2024, the Board appointed Robert D. Cook II, a designee of Gilead Sciences, Inc. ("Gilead"), to serve on the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1426800/000095017024032162/0000950170-24-032162-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.